Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Preferred Shares Issued (2017 - 2023)

Fortress Biotech has reported Preferred Shares Issued over the past 7 years, most recently at $652000.0 for Q1 2023.

  • Quarterly results put Preferred Shares Issued at $652000.0 for Q1 2023, changed N/A from a year ago — trailing twelve months through Mar 2024 was $652000.0 (changed 0.0% YoY), and the annual figure for FY2021 was $17.0 million, down 56.57%.
  • Preferred Shares Issued for Q1 2023 was $652000.0 at Fortress Biotech, down from $4.2 million in the prior quarter.
  • Over the last five years, Preferred Shares Issued for FBIO hit a ceiling of $14.4 million in Q1 2020 and a floor of $263000.0 in Q2 2021.
  • Median Preferred Shares Issued over the past 4 years was $8.8 million (2019), compared with a mean of $7.8 million.
  • Biggest five-year swings in Preferred Shares Issued: soared 628.26% in 2019 and later crashed 97.71% in 2021.
  • Fortress Biotech's Preferred Shares Issued stood at $6.0 million in 2019, then skyrocketed by 118.62% to $13.2 million in 2020, then tumbled by 68.4% to $4.2 million in 2021, then plummeted by 84.37% to $652000.0 in 2023.
  • The last three reported values for Preferred Shares Issued were $652000.0 (Q1 2023), $4.2 million (Q3 2021), and $263000.0 (Q2 2021) per Business Quant data.